Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy
Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy
Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Efficacy of Short-Course Antimicrobial Treatment for Children With Acute Otitis Media and Impact on Resistance
A Phase 2b, Multicenter, Randomized, Double Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of Short-Course Antimicrobial Therapy for Young Children With Acute Otitis Media (AOM) and Impact on Antimicrobial Resistance
Status: Enrolling
Updated:  10/5/2017
Kentucky Pediatric/ Adult Research
mi
from
Bardstown, KY
Efficacy of Short-Course Antimicrobial Treatment for Children With Acute Otitis Media and Impact on Resistance
A Phase 2b, Multicenter, Randomized, Double Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of Short-Course Antimicrobial Therapy for Young Children With Acute Otitis Media (AOM) and Impact on Antimicrobial Resistance
Status: Enrolling
Updated: 10/5/2017
Kentucky Pediatric/ Adult Research
mi
from
Bardstown, KY
Click here to add this to my saved trials
Efficacy of Short-Course Antimicrobial Treatment for Children With Acute Otitis Media and Impact on Resistance
A Phase 2b, Multicenter, Randomized, Double Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of Short-Course Antimicrobial Therapy for Young Children With Acute Otitis Media (AOM) and Impact on Antimicrobial Resistance
Status: Enrolling
Updated:  10/5/2017
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Efficacy of Short-Course Antimicrobial Treatment for Children With Acute Otitis Media and Impact on Resistance
A Phase 2b, Multicenter, Randomized, Double Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of Short-Course Antimicrobial Therapy for Young Children With Acute Otitis Media (AOM) and Impact on Antimicrobial Resistance
Status: Enrolling
Updated: 10/5/2017
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Brain Imaging of Tinnitus
Neural Modeling and Brain Imaging of Tinnitus
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Brain Imaging of Tinnitus
Neural Modeling and Brain Imaging of Tinnitus
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS
Assessing the Relationship Between Fatigue and Mitochondrial Toxicity in Patients With HIV/AIDS
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS
Assessing the Relationship Between Fatigue and Mitochondrial Toxicity in Patients With HIV/AIDS
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
Status: Enrolling
Updated:  10/6/2017
Rockefeller University
mi
from
New York, NY
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
Status: Enrolling
Updated: 10/6/2017
Rockefeller University
mi
from
New York, NY
Click here to add this to my saved trials
One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning
Randomized Trial of One Versus Three Hyperbaric Oxygen Treatments for Acute CO Poisoning
Status: Enrolling
Updated:  10/9/2017
Intermountain LDS Hospital
mi
from
Salt Lake City, UT
One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning
Randomized Trial of One Versus Three Hyperbaric Oxygen Treatments for Acute CO Poisoning
Status: Enrolling
Updated: 10/9/2017
Intermountain LDS Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning
Randomized Trial of One Versus Three Hyperbaric Oxygen Treatments for Acute CO Poisoning
Status: Enrolling
Updated:  10/9/2017
Intermountain Medical Center
mi
from
Salt Lake City, UT
One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning
Randomized Trial of One Versus Three Hyperbaric Oxygen Treatments for Acute CO Poisoning
Status: Enrolling
Updated: 10/9/2017
Intermountain Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy of Three Toothpastes Using an in Situ Caries Model
Clinical Efficacy of Three Experimental Toothpastes Using an in Situ Caries Model
Status: Enrolling
Updated:  10/11/2017
GSK Investigational Site
mi
from
Indianapolis, IN
Efficacy of Three Toothpastes Using an in Situ Caries Model
Clinical Efficacy of Three Experimental Toothpastes Using an in Situ Caries Model
Status: Enrolling
Updated: 10/11/2017
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase III Study Evaluating Topical Benzocaine for Treatment of Acute Otitis Media in Children
Phase III, Multicenter, Randomized, Double-Blind, Placebo- Controlled Parallel-Designed Evaluation to Assess Safety and Efficacy of Topical Benzocaine for Treatment of Pain Associated With Acute Otitis Media in Children Ages 5 to 12 Years
Status: Enrolling
Updated:  10/11/2017
Cyn3rgy Research
mi
from
Gresham, OR
Phase III Study Evaluating Topical Benzocaine for Treatment of Acute Otitis Media in Children
Phase III, Multicenter, Randomized, Double-Blind, Placebo- Controlled Parallel-Designed Evaluation to Assess Safety and Efficacy of Topical Benzocaine for Treatment of Pain Associated With Acute Otitis Media in Children Ages 5 to 12 Years
Status: Enrolling
Updated: 10/11/2017
Cyn3rgy Research
mi
from
Gresham, OR
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Northwest Alabama Cancer Center, PC
mi
from
Muscle Shoals, AL
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Northwest Alabama Cancer Center, PC
mi
from
Muscle Shoals, AL
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Saint Joseph Medical Center
mi
from
Burbank, CA
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Saint Joseph Medical Center
mi
from
Burbank, CA
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Compassionate Cancer Center
mi
from
Fountain Valley, CA
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Compassionate Cancer Center
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Wilshire Oncology
mi
from
La Verne, CA
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Wilshire Oncology
mi
from
La Verne, CA
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Compassionate Cancer Center
mi
from
Riverside, CA
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Compassionate Cancer Center
mi
from
Riverside, CA
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Scripps Cancer Center
mi
from
San Diego, CA
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Scripps Cancer Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Washington Cancer Institute
mi
from
Washington, D.C.,
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Washington Cancer Institute
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Integrated Community Oncology Network, LLC
mi
from
Jacksonville, FL
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Integrated Community Oncology Network, LLC
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Southeastern Gynecologic Oncology
mi
from
Atlanta, GA
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Southeastern Gynecologic Oncology
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Augusta Oncology
mi
from
Augusta, GA
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Augusta Oncology
mi
from
Augusta, GA
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Medical College of Georgia
mi
from
Augusta, GA
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Medical College of Georgia
mi
from
Augusta, GA
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Summit Cancer Center
mi
from
Savannah, GA
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Summit Cancer Center
mi
from
Savannah, GA
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Ingalls Cancer Research Center
mi
from
Harvey, IL
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Ingalls Cancer Research Center
mi
from
Harvey, IL
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Iowa Blood and Cancer Care PLC
mi
from
Cedar Rapids, IA
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Iowa Blood and Cancer Care PLC
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Frederick Memorial Hospital
mi
from
Frederick, MD
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Frederick Memorial Hospital
mi
from
Frederick, MD
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Park Nicollet Institute
mi
from
Saint Louis Park, MN
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Park Nicollet Institute
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Hematology-Oncology Centers of the Northern Rockies PC
mi
from
Billings, MT
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Hematology-Oncology Centers of the Northern Rockies PC
mi
from
Billings, MT
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Montana Cancer Institute
mi
from
Missoula, MT
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Montana Cancer Institute
mi
from
Missoula, MT
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Sparta Cancer Center
mi
from
Sparta, NJ
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Sparta Cancer Center
mi
from
Sparta, NJ
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Forsyth Regional Cancer Center
mi
from
Winton, NC
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Forsyth Regional Cancer Center
mi
from
Winton, NC
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Cancer Care Associates
mi
from
Tulsa, OK
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Cancer Care Associates
mi
from
Tulsa, OK
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Geisinger Medical Center
mi
from
Danville, PA
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Mount Nittany Medical Center
mi
from
State College, PA
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Mount Nittany Medical Center
mi
from
State College, PA
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Chester County Hospital
mi
from
West Chester, PA
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Chester County Hospital
mi
from
West Chester, PA
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Charleston Hematology Oncology, PA
mi
from
Charleston, SC
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Charleston Hematology Oncology, PA
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
C. Michael Jones, MD, PC
mi
from
Germantown, TN
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
C. Michael Jones, MD, PC
mi
from
Germantown, TN
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
McLeod Cancer & Blood Center
mi
from
Johnson City, TN
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
McLeod Cancer & Blood Center
mi
from
Johnson City, TN
Click here to add this to my saved trials
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated:  10/12/2017
Cancer Outreach Assoc. / Outreach Clinical Trial Consortium
mi
from
Abingdon, VA
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents
Status: Enrolling
Updated: 10/12/2017
Cancer Outreach Assoc. / Outreach Clinical Trial Consortium
mi
from
Abingdon, VA
Click here to add this to my saved trials
Transvaginal Appendectomy
Transvaginal Appendectomy
Status: Enrolling
Updated:  10/13/2017
Yale-New Haven Hospital
mi
from
New Haven, CT
Transvaginal Appendectomy
Transvaginal Appendectomy
Status: Enrolling
Updated: 10/13/2017
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
UAB Comprehensive Cancer Center
mi
from
Birmingham, AL
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
UAB Comprehensive Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Arizona Center for Cancer Care - Peoria
mi
from
Peoria, AZ
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Arizona Center for Cancer Care - Peoria
mi
from
Peoria, AZ
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Arizona Oncology Services Foundation
mi
from
Phoenix, AZ
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Arizona Oncology Services Foundation
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Kaiser Permanente - Division of Research - Oakland
mi
from
Oakland, CA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Kaiser Permanente - Division of Research - Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Rohnert Park Cancer Center
mi
from
Rohnert Park, CA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Rohnert Park Cancer Center
mi
from
Rohnert Park, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Kaiser Permanente Medical Center - Roseville
mi
from
Roseville, CA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Kaiser Permanente Medical Center - Roseville
mi
from
Roseville, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Kaiser Permanente Santa Clara Medical Center
mi
from
Santa Clara, CA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Kaiser Permanente Santa Clara Medical Center
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Kaiser Permanente Medical Center - South San Francisco
mi
from
South San Francisco, CA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Kaiser Permanente Medical Center - South San Francisco
mi
from
South San Francisco, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Urology Center of Colorado
mi
from
Denver, CO
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Urology Center of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials